With earnings from major media and entertainment companies disappointing many shareholders, we decided to see if this trend is here to stay, or just a bump in the road. Many pay-TV subscribers are cutting their cords, and switching to cheaper alternatives, such as Netflix and Sling TV. Shares of Time Warner, Discovery Communications, and Twenty-First Century Fox plunged 9%, 12%, and 7%, respectively. Poor earnings reports have a lot of people on Wall Street bearish, but not all. Here are some of the best entertainment stocks TheStreet Quant Ratings says you should consider looking at. Number 3 is Twenty-First Century Fox. With an 'A-' rating, the company's strengths can be seen in its attractive valuation levels and expanding profit margins. 2nd is, Time Warner. This rating is an 'A.' Time Warner thrives in its expanding profit margins and revenue growth. Number 1 is Walt Disney. With an 'A+' rating the company flourishes in its increase in net income and solid stock price performance. TheStreet Ratings are algorithmic stock picks based on 32 major data points. S&P 500 stocks rated 'buy' yielded a 16-and-a-half-percent return in 2014, beating the S&P 500 Total Return Index by more than 300 basis points. For the full reports on these stocks, you can check out TheStreet.com/QuantRatings.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.